a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies
Industry MedicalSpecialties
A.I.dvisor tells us that CNTGF and IRIX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTGF and IRIX's prices will move in lockstep.
Ticker / NAME | Correlation To CNTGF | 1D Price Change % | ||
---|---|---|---|---|
CNTGF | 100% | +7.50% | ||
IRIX - CNTGF | 28% Poorly correlated | +0.53% | ||
MASS - CNTGF | 26% Poorly correlated | +0.82% | ||
POAI - CNTGF | 25% Poorly correlated | -3.88% | ||
CSTL - CNTGF | 22% Poorly correlated | -2.72% | ||
MGRM - CNTGF | 22% Poorly correlated | -0.62% | ||
More |